Dr Scher is Associate Professor of Medicine and Director of the Psoriatic Arthritis Center at New York University School of Medicine, New York City, NY. He received his MD from Maimónides University, Buenos Aires, Argentina and completed his internal medicine residency and rheumatology fellowship at New York University. His research interests include the immune and environmental features that enhance risk for transition from psoriasis to psoriatic arthritis (PsA), the mechanisms behind microbiome perturbations in psoriatic and rheumatoid disease, and the pharmacomicrobiomics of disease modifying anti-rheumatic drugs and immunotherapies in human rheumatoid arthritis and PsA. Dr Scher’s work is supported by grants from the National Institutes of Health (NIH), the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Psoriasis Foundation and Bloomberg Philanthropies among others.
Dr Scher is a founding member of the Psoriasis & Psoriatic Arthritis Clinics Multicenter Advancement Network and director of the NYU Advanced Course in Psoriasis and Psoriatic Arthritis (since 2015). He is a past member of the US Food & Drug Administration Arthritis Advisory Committee (2016–2020) and currently serves as vice-chair of the National Psoriasis Foundation Scientific Advisory Committee (2021) and as standing member of the NIH Arthritis, Connective Tissue and Skin Sciences Study Section (2021).